FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,939 Cr | ₹3,643 Cr | ₹3,317 Cr | ₹3,180 Cr | ₹3,038 Cr |
What is the latest Total Liabilities ratio of FDC ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹3,939 Cr |
| Mar2025 | ₹3,643 Cr |
| Mar2024 | ₹3,317 Cr |
| Mar2023 | ₹3,180 Cr |
| Mar2022 | ₹3,038 Cr |
How is Total Liabilities of FDC Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,939 Cr | 8.11 | |
| Mar2025 | ₹3,643 Cr | 9.85 | |
| Mar2024 | ₹3,317 Cr | 4.31 | |
| Mar2023 | ₹3,180 Cr | 4.66 | |
| Mar2022 | ₹3,038 Cr | - | |
Compare Total Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹5,280.4 Cr | -3.3% | -5.3% | -28.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -3.3% |
-5.3% |
-28.1% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses